Living donor liver transplantation for fulminant hepatic failure--medical treatment organization in Kyushu University

Taketoshi Suehiro, Mitsuo Shimada, Keiji Kishikawa, Yuji Soejima, Tomoharu Yoshizumi, Yoshihiko Maehara, Rie Nakao, Kazuhiro Hayashida, Makoto Nakamuta, Hiroshi Honda, Kazuo Irita, Kenji Kodama, Shoichi Inaba, Takuro Taniyama

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)


Liver transplantation has been recognized as an effective therapeutic method for end-stage liver disease in Japan. Fulminant hepatic failure is also an indication for liver transplantation, and the number of patients undergoing liver transplantation has been increasing. Reversibility and urgency are characteristics of fulminant hepatitis. If given appropriate critical support, many patients recover spontaneously. However, many patients develop cerebral edema or multiorgan failure before the liver can regenerate. From October 1996 to July 2002, living donor liver transplantation (LDLT) was performed to 84 end stage liver disease patients in Kyushu University. Twenty-four (28.6%) of 84 LDLTs were for fulminant hepatic failure. In Kyushu University, LDLT candidates including urgent cases were discussed with indication in the liver transplantation committee (the medical professions division and an outside-the-university committee are included) and then the coordinator committee performs informed consent. LDLT can be performed only by cooperation of each section concerned such as Transfusion part, Medicine part, Radiation part, Operation part, Intensive Care Unit and so on. In this paper, we outline about fulminant hepatic failure and living donor liver transplantation, and describe the fulminant hepatitis medical treatment organization in Kyushu University.

Original languageEnglish
Pages (from-to)141-152
Number of pages12
JournalFukuoka igaku zasshi = Hukuoka acta medica
Issue number8
Publication statusPublished - Aug 2002

All Science Journal Classification (ASJC) codes

  • General Medicine


Dive into the research topics of 'Living donor liver transplantation for fulminant hepatic failure--medical treatment organization in Kyushu University'. Together they form a unique fingerprint.

Cite this